Aeterna Zentaris, Inc. (USA) (NASDAQ:AEZS)
CAPS Rating:
A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.
A growing global biopharmaceutical company focused on endrocrine therapy and oncology, in drug discovery, development and commercialization.